NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2019 | $3,000 | -75.0% | 160 | -50.8% | 0.00% | – |
| Q2 2019 | $12,000 | -47.8% | 325 | -52.2% | 0.00% | – |
| Q1 2019 | $23,000 | +15.0% | 680 | +9.7% | 0.00% | – |
| Q4 2018 | $20,000 | +1900.0% | 620 | +3000.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 20 | -71.4% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 70 | +25.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -98.7% | 56 | -99.0% | 0.00% | – |
| Q1 2016 | $77,000 | +7600.0% | 5,575 | +9855.4% | 0.00% | – |
| Q4 2015 | $1,000 | -96.8% | 56 | -98.0% | 0.00% | – |
| Q3 2015 | $31,000 | -13.9% | 2,832 | 0.0% | 0.00% | – |
| Q2 2015 | $36,000 | +12.5% | 2,832 | 0.0% | 0.00% | – |
| Q1 2015 | $32,000 | -27.3% | 2,832 | 0.0% | 0.00% | – |
| Q4 2014 | $44,000 | – | 2,832 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |